default author photo

Thierry Lecomte

CHRU Tours

SCHOLARLY PAPERS

3

DOWNLOADS

110

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Integrative analysis of circulating biomarkers of colorectal cancer combining mid-infrared spectroscopy and targeted metabolomics

Number of pages: 36 Posted: 26 Dec 2025
affiliation not provided to SSRN, Université de Tours, Centre-Val de Loire, Université de Tours, Centre-Val de Loire, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Dijon - Dijon University Hospital Center, INSERM UMR 1231 CADIR, INSERM UMR 1231 CADIR, CHRU Tours, CHRU Tours and affiliation not provided to SSRN
Downloads 62 (942,565)

Abstract:

Loading...

Colorectal cancer, risk stratification, MIR spectrometry : metabolomics, multi-modal data, statistical pipeline

2.

Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: a retrospective study by AGEO

Number of pages: 23 Posted: 21 Jan 2026
affiliation not provided to SSRN, Gustave Roussy, Université de Poitiers - Gastroenterology Department, University of Besançon - University Hospital Besançon, affiliation not provided to SSRN, CHRU Tours, Université Paris Cité, Bergonié Institute, affiliation not provided to SSRN, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, affiliation not provided to SSRN, Centre Hospitalier Universitaire de Toulouse, affiliation not provided to SSRN, Assistance Publique-Hôpitaux de Paris - Hôpital Cochin, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, Centre Eugène Marquis - Medical Oncology, affiliation not provided to SSRN, Groupe Hospitalier Diaconesses-Croix St-Simon, affiliation not provided to SSRN and University of Lille - CHU Lille
Downloads 27 (1,359,097)

Abstract:

Loading...

Small bowel adenocarcinoma, metastasis, targeted therapies, chemotherapy

3.

Nal-Iri/Lv5-Fu Versus Paclitaxel as Second-Line Therapy in Patients with Metastatic Esophageal Squamous Cell Carcinoma (Prodige 62-Ffcd 1701-Oesiri)

Number of pages: 29 Posted: 16 Jul 2025
Université de Poitiers - Gastroenterology Department, affiliation not provided to SSRN, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, University of Franche-Comté, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Limoges - CHU Limoges, Groupe Hospitalier Diaconesses-Croix St-Simon, Perpignan Hospital Center, affiliation not provided to SSRN, CHU de Reims, CHU Rennes, CHU Rouen, CHRU Tours, INSERM UMR 1231 CADIR and affiliation not provided to SSRN
Downloads 21 (1,436,435)

Abstract:

Loading...

Esophageal cancer, irinotecan, paclitaxel, squamous cell carcinoma